Recombinant CD14 (Atibuclimab Biosimilar) antibody

Catalog No. ABIN7581280

The Human Monoclonal anti-CD14 (Atibuclimab Biosimilar) antibody has been validated for BLI, ELISA, FACS, Func and SPR. It is suitable to detect CD14 (Atibuclimab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD14 (Atibuclimab Biosimilar) antibody (ABIN7581280)

Target: CD14 (Atibuclimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD14 (Atibuclimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD14 (Atibuclimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD14 Reference Antibody (atibuclimab)

Characteristics: Anti-CD14 Reference Antibody (atibuclimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD14 (Atibuclimab Biosimilar)

Target: CD14 (Atibuclimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P08571